A Phase III, Multicenter, Randomized Study of Olvimulogene Nanivacirepvec Followed by Platinum-Doublet Chemotherapy and Bevacizumab Compared with Platinum-Doublet Chemotherapy and Bevacizumab in Women with Platinum-Resistant/refractory Ovarian Cancer.
International Journal of Gynecological Cancer（2023）
Key words
Ovarian Cancer,Surgical Oncology,Carcinoma, Ovarian Epithelial,Gynecology
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined